Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
Background: To compare survival outcomes of patients with advanced or metastatic non-small cell lung cancer (NSCLC) who received immunotherapy as first-, second- or beyond line, versus matched patients receiving standard chemotherapy with special characterization of hyperprogressors. Methods: A retr...
- Autores:
-
Ruiz-Patinõ, Alejandro
Arrieta, Oscar
Cardona-Mendoza, Andrés Felipe
Martín, Claudio Marcelo
Raez, Luis Estuardo
Zatarain-Barrón, Zyanya Lucia
Barron, Feliciano
Ricaurte, Luisa María
Bravo-Garzón, María A.
Mas, Luis A.
Corrales, Luis
Rojas Puentes, Leonardo
Lupinacci, Lorena
Perazzo, Florencia
Bas, Carlos Arturo
Carranza, Omar E.
Puparelli, Carmen
Rizzo, Miguel M
Ruiz, Rossana
Rolfo, Christian
Archila, Pilar
Rodríguez, July F.
Vargas Báez, Carlos Alberto
Carranza, Hernán
Otero, Jorge Miguel
Pino, Luis Eduardo
Ortíz, Carlos
Laguado, Paola
Rosell, Rafael Costa
- Tipo de recurso:
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/2022
- Palabra clave:
- Estadificación de neoplasias
Sistema nervioso central
Estudios de cohortes
Adult
Immunotherapy
Lung neoplasms
- Rights
- License
- Attribution 4.0 International